CD158k/KIR3DL2 Is a New Phenotypic Marker of Sezary Cells: Relevance for the Diagnosis and Follow-Up of Sezary Syndrome
Open Access
- 1 March 2004
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 122 (3) , 820-823
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Polymorphic expression of CD158k/p140/KIR3DL2 in Sézary patientsBlood, 2003
- Killer cell immunoglobulin‐like receptor expression delineates in situ Sézary syndrome lymphocytesThe Journal of Pathology, 2002
- Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomasJournal of the American Academy of Dermatology, 2002
- Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral BloodAmerican Journal of Clinical Pathology, 2001
- CD4+ cutaneous T-cell lymphoma cells express the p140–killer cell immunoglobulin-like receptorBlood, 2001
- The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cellsBritish Journal of Dermatology, 2001
- Isolation of Tumor-Specific Cytotoxic CD4+ and CD4+CD8dim+ T-Cell Clones Infiltrating a Cutaneous T-Cell LymphomaBlood, 1998
- Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytesImmunological Reviews, 1997
- The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.Journal of Experimental Medicine, 1996
- Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresisBlood, 1995